Deinove, Avril sign deal to assess commercial potential of 20 new bacterial strains
In France, Deinove and Avril announced that they would screen a 6,000-bacteria bank of Deinococci and other genera to identify 20 strains capable of producing useful molecules in terms of animal nutrition and health, and AVRIL Group would characterize the molecules produced and to perform application tests. The goal of this new stage is to confirm each […]











